Next Generation

Capabilities

GenomOncology’s advanced platform addresses all of your needs in building a leading precision oncology program – from your molecular pathology lab to your point-of- care solutions.

Clinical Trial Enrollment

Cancer trials are getting more complex and identifying eligible patients has been increasingly challenging. GenomOncology’s clinical trial capabilities optimize patient identification to increase trial enrollments.
Learn more

"OMICS"-EHR Integration

Integrate discrete genomic data into the EHR using standards-based HL7 messages to put critical information directly in the hands of physicians at the point-of-care.
Learn more

Pathology Decision Support

GO tools integrate molecular and clinical information, providing pathologists and oncologists with powerful decision-support tools that enable treatment selection based on FDA, NCCN, ASCO, MCG guidelines, and patient identifiers. Our tools deliver support in real-time via a seamless and integrated platform.
Learn more

Oncology Decision Support

The “avalanche” of OMICS data is challenging for any oncologist. GenomOncology’s tools do the hard work to make precision medicine a reality for your patients so you don't have to.
Learn more

Assay
Validation

Validating the analytical performance of Next-Generation Sequencing assays is complex and time consuming. Speed up your time-to-launch with the GO Validation Toolkit.
Learn more

Cancer Informatics

Modern cancer treatments are difficult to design without big data and informatics. Utilize GenomOncology APIs and analytics tools to always be at the forefront of oncology.
Learn more
  • Clinical Trial Enrollment MORE>
  • "OMICS"-EHR Integration MORE>
  • Pathology Decision Support MORE>
  • Oncology Decision Support MORE>
  • Assay
    Validation MORE>
  • Cancer Informatics MORE>

Tailored Solutions

University of Nebraska Medical Center

In 2018, GenomOncology collaborated with UNMC to develop a proprietary solution called GO Connect, a software that integrates with current EHRs by generating standard HL7 messages to describe somatic mutations.

READ MORE

Schedule a demo